Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 24.64 | (52.29) | (33.50)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 107.32 | 12.15 | 5.50¢ | 66.2 | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Dynavax, Merck team up on hepatitis B vaccine | 02-Nov-2007 | BayArea.com |
| Merck Buys License to Sell New Vaccine for Hepat... | 01-Nov-2007 | New York Times |
| Business Digest | 20-Jan-2006 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 3.64 |
| Change Today | $ -0.01 |
| % Change | -0.27 % |
| 52 Week High | $5.26 |
| 52 Week Low | $1.82 |
| Volume | 980,257 |
| Shares Issued | 156.68m |
| Market Cap | $570.30m |
| Beta | 1.47 |
| RiskGrade | 379 |
| Strong Buy | 4 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

| Time | Volume / Share Price |
| 16:00 | 29,424 @ $3.64 |
| 15:59 | 300 @ $3.65 |
| 15:59 | 100 @ $3.65 |
| 15:59 | 100 @ $3.65 |
| 15:59 | 300 @ $3.65 |
You are here: research